Evidence map›Paper›PMID 35491996›Full record

ArticleJournal of the American Heart Association2022

Association Between the Acidemia, Lactic Acidosis, and Shock Severity With Outcomes in Patients With Cardiogenic Shock.

Jacob C Jentzer, Benedikt Schrage, Parag C Patel, Kianoush B Kashani, Gregory W Barsness, David R Holmes, Stefan Blankenberg, Paulus Kirchhof, Dirk Westermann

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Observational
  18. Article
  19. Current and novel biomarkers in cardiogenic shock.European journal of heart failure · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jacob C JentzerDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN.ORCID 0000-0002-6366-2859
Benedikt SchrageDepartment of Cardiology University Heart and Vascular Center UKE Hamburg Hamburg Germany.ORCID 0000-0001-9041-3922
Parag C PatelDepartment of Cardiovascular Medicine Mayo Clinic Jacksonville FL.
Kianoush B KashaniDivision of Pulmonary and Critical Care Medicine Department of Medicine Mayo Clinic Rochester MN.
Gregory W BarsnessDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN.ORCID 0000-0002-6353-6780
David R HolmesDepartment of Cardiovascular Medicine Mayo Clinic Rochester MN.ORCID 0000-0002-0037-0373
Stefan BlankenbergDepartment of Cardiology University Heart and Vascular Center UKE Hamburg Hamburg Germany.
Paulus KirchhofDepartment of Cardiology University Heart and Vascular Center UKE Hamburg Hamburg Germany.ORCID 0000-0002-1881-0197
Dirk WestermannDepartment of Cardiology and Angiology Medical Faculty University Heart Center Freiburg - Bad KrozingenUniversity of Freiburg Germany.ORCID 0000-0002-7542-1956

Funding

British Heart FoundationMedical Research Council
6 · The paper itself

Abstract

Background Lactic acidosis is associated with mortality in patients with cardiogenic shock (CS). Elevated lactate levels and systemic acidemia (low blood pH) have both been proposed as drivers of death. We, therefore, analyzed the association of both high lactate concentrations and low blood pH with 30-day mortality in patients with CS. Methods and Results This was a 2-center historical cohort study of unselected patients with CS with available data for admission lactate level or blood pH. CS severity was graded using the Society for Cardiovascular Angiography and Intervention (SCAI) shock classification. All-cause survival at 30 days was analyzed using Kaplan-Meier curves and Cox proportional-hazards analysis. There were 1814 patients with CS (mean age, 67.3 years; 68.5% men); 51.8% had myocardial infarction and 53.0% had cardiac arrest. The distribution of SCAI shock stages was B, 10.8%; C, 30.7%; D, 38.1%; and E, 18.7%. In both cohorts, higher lactate or lower pH predicted a higher risk of adjusted 30-day mortality. Patients with a lactate ≥5 mmol/L or pH <7.2 were at increased risk of adjusted 30-day mortality; patients with both lactate ≥5 mmol/L and pH <7.2 had the highest risk of adjusted 30-day mortality. Patients in SCAI shock stages C, D, and E had higher 30-day mortality in each SCAI shock stage if they had lactate ≥5 mmol/L or pH <7.2, particularly if they met both criteria. Conclusions Higher lactate and lower pH predict mortality in patients with cardiogenic shock beyond standard measures of shock severity. Severe lactic acidosis may serve as a risk modifier for the SCAI shock classification. Definitions of refractory or hemometabolic shock should include high lactate levels and low blood pH.

Indexed as

AcidosisAcidosis, LacticShockAgedCohort StudiesFemaleHumansLactic AcidMaleShock, CardiogenicLactic Acidacidemiaacidosiscardiogenic shocklactic acidosisshock

Identifiers

PMID35491996
PMCPMC9238598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.